Stay updated with breaking news from Program On Regulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shortages, cost, and delays may reduce the effectiveness of CAR-T treatment and increase the risk of patient mortality in multiple myeloma.
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...
This Viewpoint discusses how limited-supply agreements (introduction of generic products in reduced volumes) might thwart efforts to negotiate lower prices on p
This Viewpoint looks at the lawsuits brought by pharmaceutical companies to challenge the Inflation Reduction Act of 2022, in particular claims under the First
Early next year, the chain will start producing a cheaper version of Humira, with other meds to follow. Here's what to know about biosimilar drugs.